arrow_back Trending Legislation
Share share

New Drug Advertising Ban: Three-Year Wait for Consumer Ads.

This law establishes a mandatory three-year ban on direct-to-consumer advertising for newly approved prescription drugs across all media, including social platforms. This means citizens will not see advertisements for the newest medications until a critical period for gathering safety data has passed. The goal is to ensure treatment decisions are based on medical information rather than marketing campaigns.
Key points
Pharmaceutical companies are prohibited from advertising new prescription drugs directly to consumers (TV, internet, social media) for the first three years after approval.
The ban allows time for potential side effects and drug safety profiles to be fully understood before mass marketing begins.
Even after three years, the government can still prohibit advertising if the drug is found to have significant adverse health effects.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Responsibility in Drug Advertising Act of 2024
Print number: HR 9142
Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]
Process start date: 2024-07-25